SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TAGLIATI, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.247
AS - Asia 5.036
EU - Europa 2.723
SA - Sud America 720
AF - Africa 120
Continente sconosciuto - Info sul continente non disponibili 118
OC - Oceania 8
Totale 18.972
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.016
SG - Singapore 1.870
CN - Cina 1.353
DE - Germania 600
VN - Vietnam 592
BR - Brasile 558
UA - Ucraina 432
IT - Italia 426
HK - Hong Kong 373
GB - Regno Unito 302
TR - Turchia 264
FI - Finlandia 239
FR - Francia 164
SE - Svezia 145
RU - Federazione Russa 134
BD - Bangladesh 127
JP - Giappone 119
CA - Canada 110
IN - India 95
PL - Polonia 84
MX - Messico 70
AR - Argentina 62
ID - Indonesia 43
ZA - Sudafrica 42
NL - Olanda 38
IQ - Iraq 37
BE - Belgio 30
PK - Pakistan 30
ES - Italia 29
EC - Ecuador 22
LT - Lituania 19
UZ - Uzbekistan 19
VE - Venezuela 19
AT - Austria 18
CO - Colombia 18
CL - Cile 15
EG - Egitto 15
JM - Giamaica 15
DZ - Algeria 13
PH - Filippine 13
SA - Arabia Saudita 13
JO - Giordania 11
KE - Kenya 11
IE - Irlanda 9
MA - Marocco 9
TN - Tunisia 9
CH - Svizzera 8
LB - Libano 8
TW - Taiwan 8
UY - Uruguay 8
AL - Albania 7
MY - Malesia 7
TT - Trinidad e Tobago 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
BO - Bolivia 6
IR - Iran 6
NP - Nepal 6
PY - Paraguay 6
AZ - Azerbaigian 5
GR - Grecia 5
PE - Perù 5
BG - Bulgaria 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KZ - Kazakistan 4
PS - Palestinian Territory 4
AM - Armenia 3
DK - Danimarca 3
ET - Etiopia 3
EU - Europa 3
GT - Guatemala 3
IL - Israele 3
LV - Lettonia 3
MD - Moldavia 3
PR - Porto Rico 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
CY - Cipro 2
GA - Gabon 2
KG - Kirghizistan 2
ML - Mali 2
OM - Oman 2
PA - Panama 2
SY - Repubblica araba siriana 2
TG - Togo 2
UG - Uganda 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
Totale 18.836
Salva come PNG Salva come JPEG
Città #
Ashburn 1.472
Singapore 1.270
Woodbridge 890
San Jose 728
Fairfield 716
Chandler 565
Houston 527
Jacksonville 494
Beijing 448
Santa Clara 422
Ann Arbor 380
Hong Kong 359
Seattle 300
Wilmington 266
Cambridge 215
Ho Chi Minh City 191
Los Angeles 178
Addison 150
New York 150
Munich 145
Hanoi 138
Nanjing 137
Izmir 134
Dallas 128
Council Bluffs 126
Ferrara 120
Tokyo 118
Princeton 99
Lauterbourg 91
Helsinki 88
Boardman 86
Milan 85
Shanghai 80
Warsaw 78
Dearborn 67
São Paulo 64
San Diego 60
Turku 54
Orem 51
Mexico City 48
Shenyang 44
Bremen 41
Buffalo 41
Tianjin 39
Brooklyn 37
Nanchang 36
London 34
Atlanta 32
Chicago 32
Da Nang 32
Denver 32
Montreal 32
Changsha 31
Toronto 31
Hebei 29
Johannesburg 29
Brussels 28
Chennai 28
Haiphong 28
Washington 28
Frankfurt am Main 26
Hefei 25
Jinan 25
Jakarta 24
Manchester 24
Mountain View 24
Nuremberg 22
Phoenix 22
Jiaxing 21
Kunming 20
Tappahannock 19
Amsterdam 18
Boston 18
Guangzhou 18
Rome 18
Baghdad 17
Poplar 17
San Francisco 17
Hải Dương 16
Moscow 16
Stockholm 16
Tashkent 16
Ankara 15
Falls Church 15
Norwalk 15
Brasília 14
Rio de Janeiro 14
Biên Hòa 13
City of London 13
Falkenstein 13
Verona 13
Belo Horizonte 12
Redwood City 12
Amman 11
Auburn Hills 11
Charlotte 11
Leawood 11
Bologna 10
Indiana 10
Mumbai 10
Totale 13.044
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 436
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 289
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 282
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 281
Chemical Composition of Essential Oils from Thymus vulgaris, Cymbopogon citratus, and Rosmarinus officinalis, and Their Effects on the HIV-1 Tat Protein Function 279
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 269
Igf-I influences everolimus activity in medullary thyroid carcinoma 263
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 261
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 259
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 259
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 251
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 250
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 247
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 244
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 237
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 234
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 233
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 233
Functional characterization of a new deletion in CDKN1B 5'-UTR region 232
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 229
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 225
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 223
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 221
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 220
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 218
Growth hormone excess promotes breast cancer chemoresistance 217
Growth hormone induces chemoresistance in breast cancer cells 217
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 217
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 216
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 215
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 215
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 211
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 206
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 205
miR-15a and miR-16-1 down-regulation in pituitary adenomas 205
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 204
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 204
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 204
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 202
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 201
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 197
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 193
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 190
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 189
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 187
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 187
Caffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib 187
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 186
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 184
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 184
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 182
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 182
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 182
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells 182
Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib 182
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 180
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 178
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 177
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 175
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-κB 175
Characterization of Stable Pyrazole Derivatives of Curcumin with Improved Cytotoxicity on Osteosarcoma Cell Lines 171
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 168
Effects of pasireotide on bronchial carcinoids in primary culture 168
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 167
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 165
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 165
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 163
Real-time PCR is useful to detect menin gene deletions 163
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 160
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 159
Selected terpenes from leaves of Ocimum basilicum L. induce hemoglobin accumulation in human K562 cells 159
Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line TT 158
Thyroid Nodule Screening for Malignancy: A Prospective Study on Ultrasonographic/Clinical Profile, Cytology and BRAF V600E Mutation Evaluation 158
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 157
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 157
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 156
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 152
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 150
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 149
Somatostatin inhibits a medullary thyroid carcinoma cell line growth by activating SHP-1 147
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 147
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 146
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 143
Somatostatin differentially influences proliferation and gene expression by modulating SHP-1 and cAMP pathways in a human medullary thyroid carcinoma cell line 138
A Central Contribution of TG2 Activity to the Antiproliferative and Pro-Apoptotic Effects of Caffeic Acid in K562 Cells of Human Chronic Myeloid Leukemia 137
α-Pinene, a Main Component of Pinus Essential Oils, Enhances the Expression of Insulin-Sensitive Glucose Transporter Type 4 in Murine Skeletal Muscle Cells 131
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 123
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 123
SSTR subtypes expression pattern influences the antiproliferative effects of somatostatin and lanreotide on human medullary thyroid carinomas in vitro 121
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 121
Targeting PKC in human pancreatic neuroendocrine tumor cells 120
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro 119
Validation of a murine model to study deregulated pituitary microRNA 116
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 116
miR-26a targets PRKCD in ACTH pituitary adenoma 112
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  110
null 106
null 92
Role of piuitary tumour transforming gene 1 in medullary thyroid carcinoma 82
miR-26a and cell cycle control in ACTH secreting pituitary adenoma 82
Totale 18.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.758
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.004 0 101 68 20 47 54 48 41 36 87 113 389
2022/20231.192 110 102 63 162 191 170 74 94 134 9 49 34
2023/2024908 60 66 28 19 59 105 23 373 19 13 8 135
2024/20252.397 52 46 192 66 312 328 67 70 343 243 365 313
2025/20267.182 716 302 557 785 1.199 472 967 352 683 737 250 162
2026/2027330 145 185 0 0 0 0 0 0 0 0 0 0
Totale 18.972